Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Cellivery Therapeutics Inc (268600)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,680 0    0.00%
31/12 - Real-time Data. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7268600004 
  • Volume: 0
  • Bid/Ask: 0 / 0
  • Day's Range: 6,680 - 9,280
Cellivery 6,680 0 0.00%

268600 Recent Sentiments

 
This page contains information on users’ sentiments for the Cellivery Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Nov 04, 2022 현호 진   12250 Nov 07, 2022 @ 12100 -1.22%
Jun 07, 2022 김 인주   27100 Jun 13, 2022 @ 26050 -3.87%
Jan 17, 2022 이 현우   35900 Feb 02, 2022 @ 31950 -11.00%
Dec 09, 2021 왘 우   47500 Dec 13, 2021 @ 45350 -4.53%
Nov 11, 2021 준우 이   51700 Nov 15, 2021 @ 55400 -7.16%
Oct 08, 2021 Byoung Jae Park   53800 Oct 29, 2021 @ 50200 +6.69%
Sep 29, 2021 두건 흑   57400 Oct 22, 2021 @ 52400 -8.71%
Aug 18, 2021 Sehun Kim   71500 Sep 10, 2021 @ 64800 +9.37%
Aug 10, 2021 민혁 손   78700 Sep 03, 2021 @ 72700 -7.62%
Jul 07, 2021 성재 김   104100 Jul 30, 2021 @ 84000 -19.31%
Jul 01, 2021 Chang Van   100400 Jul 23, 2021 @ 94600 -5.78%
Jun 30, 2021 준우 이   103500 Jul 05, 2021 @ 102000 +1.45%
Jun 30, 2021 준우 이   103500 Jul 05, 2021 @ 102000 +1.45%
Jun 28, 2021 커튼 암막   108200 Jul 23, 2021 @ 94600 -12.57%
Apr 23, 2021 현준 김   126900 May 14, 2021 @ 117000 -7.80%
Apr 22, 2021 jh u   128600 Apr 22, 2021 @ 128600 0.00%
Apr 01, 2021 경주 정   130200 Apr 05, 2021 @ 137800 +5.84%
Mar 29, 2021 재용 김   133900 Apr 23, 2021 @ 126100 -5.83%
Mar 23, 2021 충우 정   145800 Apr 16, 2021 @ 121600 -16.60%
Mar 19, 2021 세훈 박   143500 Apr 09, 2021 @ 131000 -8.71%
Mar 15, 2021 영민 이   134400 Apr 08, 2021 @ 130300 -3.05%
Mar 12, 2021 희정 장   135400 Apr 02, 2021 @ 136700 +0.96%
Mar 11, 2021 byeongho kang   132900 Apr 02, 2021 @ 136700 +2.86%
Mar 03, 2021 형근 이   129100 Mar 26, 2021 @ 134600 -4.26%
Mar 01, 2021 민석 손   113100 Mar 02, 2021 @ 140500 -24.23%
Feb 24, 2021 김 인주   125200 Mar 19, 2021 @ 146900 +17.33%
Jan 28, 2021 보홍 손   193650 Feb 19, 2021 @ 155100 +19.91%
Jan 27, 2021 세인 박   173000 Feb 19, 2021 @ 155100 -10.35%
Jan 26, 2021 유림 김   162800 Feb 19, 2021 @ 155100 +4.73%
Jan 26, 2021 경훈 이   162600 Feb 19, 2021 @ 155100 -4.61%
Jan 26, 2021 이 승균   162500 Feb 19, 2021 @ 155100 +4.55%
Jan 26, 2021 Tacken Chae   168550 Feb 19, 2021 @ 155100 -7.98%
Jan 26, 2021 승재 오   176150 Feb 19, 2021 @ 155100 -11.95%
Jan 26, 2021 마 석도   176600 Feb 19, 2021 @ 155100 -12.17%
Jan 26, 2021 마 석도   176600 Feb 19, 2021 @ 155100 -12.17%
Jan 26, 2021 정민 최   171500 Feb 19, 2021 @ 155100 +9.56%
Jan 25, 2021 창민 한   185750 Feb 19, 2021 @ 155100 -16.50%
Jan 25, 2021 Jang KO   185750 Feb 19, 2021 @ 155100 -16.50%
Jan 25, 2021 승민 차   182750 Feb 19, 2021 @ 155100 -15.13%
Jan 11, 2021 Chang Van   90500 Feb 05, 2021 @ 154400 +70.61%
Dec 23, 2020 재용 김   165400 Jan 15, 2021 @ 186800 -12.94%
Dec 14, 2020 길현 이   183500 Jan 08, 2021 @ 186000 +1.36%
Oct 21, 2020 김 인주   205700 Nov 13, 2020 @ 206800 +0.53%
Sep 01, 2020 승재 오   226700 Sep 25, 2020 @ 191000 -15.75%
Aug 25, 2020 김 인주   195000 Sep 18, 2020 @ 216300 +10.92%
Aug 22, 2020 Sehun Kim   173000 Sep 19, 2020 @ 216300 +25.03%
Aug 21, 2020 JIN HO SONG   174200 Sep 11, 2020 @ 202200 +16.07%
Aug 21, 2020 JIN HO SONG   174200 Aug 21, 2020 @ 174200 0.00%
Aug 20, 2020 재용 김   179800 Sep 11, 2020 @ 202200 +12.46%
Aug 19, 2020 경선 유   179200 Sep 11, 2020 @ 202200 +12.83%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

268600 Comments

Write your thoughts about Cellivery Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email